Trials / Terminated
TerminatedNCT05788497
Efficacy and Safety of Hemorrane Plus Versus Hemorrane and Versus Placebo in Patients With Uncomplicated Haemorrhoids
Multicentre, Double-blind, Randomised Clinical Trial to Evaluate and Compare the Efficacy and Safety of Hemorrane Plus (Hemorrane® + Benzocaine) With Hemorrane® and With Placebo in Patients With Uncomplicated Haemorrhoids
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Faes Farma, S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a Multicentre, double-blind, randomised clinical trial to evaluate and compare the efficacy and safety of Hemorrane Plus (Hemorrane® + benzocaine) with Hemorrane® and with placebo in patients with uncomplicated haemorrhoids.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hemorrane plus | Hemorrane 10 mg/g rectal ointment + 30 mg/g benzocaine |
| DRUG | Hemorrane | Hemorrane 10 mg/g rectal ointment |
| DRUG | Placebo | Rectal ointment |
Timeline
- Start date
- 2023-03-30
- Primary completion
- 2024-01-04
- Completion
- 2024-01-04
- First posted
- 2023-03-29
- Last updated
- 2024-02-28
Locations
13 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT05788497. Inclusion in this directory is not an endorsement.